Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec 28:2020:6682251.
doi: 10.1155/2020/6682251. eCollection 2020.

Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19

Fatemeh Yavari  1 , Sara Raji  2 , Fatemeh Moradi  2 , Morteza Saeidi  3
Affiliations
Case Reports

Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19

Fatemeh Yavari et al. Case Rep Neurol Med. .

Abstract

COVID-19, as a global concern and pivotal issue in the healthcare system, could have various presentations, leading to difficulty in diagnosis and management. Neuroinvasive potency, as claimed by preliminary studies, is a considerable pathogenesis. Serious neurological disorders like multiple sclerosis (MS) were out of the blue to be the first demonstration of COVID-19. This report highlights the representation of MS in a young woman, which resulted in a COVID-19 diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Head-MRI T1 sequence with gadolinium demonstrates various hypersignal lesions in favor of active demyelinating plaques in left temporal and right frontal areas of the brain. (b, c) Axial and (d) sagittal FLAIR views show plaques with larger sizes in deeper areas of the brain.
See this image and copyright information in PMC

References

    1. Ellul M., Varatharaj A., Nicholson T. R., et al. Defining Causality in COVID-19 and Neurological Disorders. London, UK: BMJ Publishing Group Ltd; 2020. - PMC - PubMed
    1. Beghi E., Feigin V., Caso V., Santalucia P., Logroscino G. COVID-19 infection and neurological complications: present findings and future predictions. Neuroepidemiology. 2020;54(4):1–6. doi: 10.1159/000508991. - DOI - PMC - PubMed
    1. Correia A. O., Feitosa P. W. G., de Sousa Moreira J. L., Nogueira S. ÁR., Fonseca R. B., Nobre M. E. P. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurology, Psychiatry and Brain Research. 2020;37:27–32. doi: 10.1016/j.npbr.2020.05.008. - DOI - PMC - PubMed
    1. Kwong K. C. N. K., Mehta P. R., Shukla G., Mehta A. R. COVID-19, SARS and MERS: a neurological perspective. Journal of Clinical Neuroscience. 2020;77:13–16. doi: 10.1016/j.jocn.2020.04.124. - DOI - PMC - PubMed
    1. Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clinical Neurology and Neurosurgery. 2020;194 doi: 10.1016/j.clineuro.2020.105921.105921 - DOI - PMC - PubMed

Publication types

LinkOut - more resources